Our results in two antidepressant-sensitive tests, the force swim and TSTs, and three anxiogenic tests, the open field, the elevated plus maze and the dark-light tests, suggest that deletion of Akt3 increases susceptibility to develop symptoms related to depression and anxiety. The gene discussed is AKT3; the disease is Anxiety.